Table 1 Patient characteristics
No. of patients | 101 |
|---|---|
Age (years) | |
Mean | 59.2 |
Median | 61 |
Range | 21–87 |
FIGO stage | |
I | 10 |
II | 8 |
III | 60 |
IV | 23 |
Grading | |
1 | 6 |
2 | 29 |
3 | 58 |
Not determined/unknown | 8 |
Lymph node metastasis | |
N0 | 31 |
N1 | 55 |
NX | 15 |
Residual tumour after surgery | |
Microscopic | 67 |
<0.5 cm | 7 |
0.5–1 cm | 10 |
1–2 cm | 2 |
>2 cm | 6 |
Not determined/unknown | 9 |
Histologic subtype | |
Serous | 74 |
Mucinous | 6 |
Endometrioid | 5 |
Clear cell | 1 |
Undifferentiated | 7 |
Mixed differentiation | 8 |
Platinum-based first-line chemotherapy | |
Adjuvant | 90 |
Neoadjuvant | 6 |
None/unknown | 5 |
CA 125 before surgery (kU l−1) | |
Mean | 2178 |
Median | 436 |
Range | 21–47 000 |
Survival (months), n=99 | |
Progression-free survival | |
Mean | 19.7 |
Median | 15.2 |
Range | 0.4–98 |
Overall survival | |
Mean | 24.4 |
Median | 20 |
Range | 0.4–98 |
